Pain Medicine, Interventional Pain Medicine · Athens, GA
NPI
1730150194
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1765 Old West Broad St, Bldg 1 Ste 200
Athens, GA, 30606
Phone (706) 208-0451
Groups this clinician bills Medicare through
Medicare paid, 2024
$361K
5,672 services
Medicare patients, 2024
553
Average age 68
Drug cost, 2024
$665K
16,975 prescriptions
Company payments, 2025
$79.6
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Ellis was code 99213 (office e&m - established), 5,002 times for 541 patients. In total Mark A Ellis billed 5,672 services in 33 codes, and Medicare paid $361K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 5,002 | 541 | $63.71 | $319K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 146 | 87 | $0.09 | $12.53 |
| 99442 Telephone Services | Office | 112 | 62 | $60.57 | $6,784 |
| 99214 Office E&M - Established | Office | 94 | 80 | $73.97 | $6,953 |
| 99441 Telephone Services | Office | 54 | 33 | $33.65 | $1,817 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 33 | 25 | $0.49 | $16.31 |
| 62323 Nerve Block Injection - Back | Office | 30 | 26 | $183.32 | $5,500 |
| 99211 Office E&M - Established | Office | 26 | 26 | $16.71 | $435 |
| 64493 Nerve Block Injection - Back | Office | 20 | 17 | $116.90 | $2,338 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 18 | 13 | $319.29 | $5,747 |
| 64483 Nerve Block Injection - Back | Office | 18 | 17 | $191.61 | $3,449 |
| 99203 Office E&M - New | Office | 13 | 13 | $65.19 | $847 |
By year: 2022 $1.0M for 12,584 services; 2023 $576K for 8,212 services; 2024 $361K for 5,672 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 672 | 504 | $12.15 | $8,168 |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 662 | 487 | $241.63 | $160K |
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Ellis prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 5,735 prescriptions and refills. In total Mark A Ellis wrote 16,975 Medicare prescriptions that cost $665K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 5,735 | 5,737 | 566 | $199K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 5,047 | 5,049 | 525 | $169K |
| Oxycodone Hcl Generic | 2,246 | 2,246 | 250 | $35K |
| Hydromorphone Hcl Generic | 624 | 624 | 79 | $10K |
| Morphine Sulfate Er Morphine Sulfate | 606 | 606 | 96 | $9,856 |
| Fentanyl Generic | 232 | 232 | 30 | $22K |
| Gabapentin Generic | 202 | 214 | 82 | $2,438 |
| Pregabalin Generic | 197 | 199 | 82 | $5,144 |
| Tramadol Hcl Generic | 169 | 169 | 54 | $1,261 |
| Methadone Hcl Generic | 168 | 168 | 24 | $1,559 |
| Morphine Sulfate Generic | 159 | 159 | 28 | $4,621 |
| Buprenorphine Generic | 144 | 144 | 43 | $29K |
| Tizanidine Hcl Generic | 114 | 122 | 45 | $787 |
| Cyclobenzaprine Hcl Generic | 110 | 115 | 44 | $1,273 |
| Zolpidem Tartrate Generic | 77 | 77 | 26 | $266 |
Brand drugs: 462 claims; generic drugs: 16,513 claims; opioid claims: 15,437.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A Ellis $79.6 ($79.6 in general payments such as food, travel and fees) from 2 companies. The largest payer was Valinor Pharma, LLC with $42.46.
| Company | Payments | Amount |
|---|---|---|
| Valinor Pharma, LLC | 2 | $42.46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $37.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.